Bear-Moon Clinical Case Study
The BEAR Implant is the first medical advancement to enable your body to heal its own torn anterior cruciate ligament (ACL). That’s a big deal, because until now your ACL would have been replaced with either another tendon from your body or a tendon from a deceased donor. The BEAR Implant is different because it works with your own blood to heal the torn ends of your ACL back together.
The BEAR Implant was approved by the U.S. Food and Drug Administration in 2020, and Miach continues to expand its base of evidence through post-market and label expansion studies. The BEAR-MOON study is comparing traditional ACL reconstruction with a patellar tendon autograft to ACL restoration using the BEAR implant. Participants will be randomized to receive one of these treatments.
This NIH-funded study is enrolling 200 participants who:
- Are 18-55 years of age
- Had an ACL tear within 50 days of the expected surgery date
- Have a BMI less than 35 kg/m2